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Abstract
Almost 30 years ago, the monoclonal antibody Py was developed to detect pyramidal neurons
in the CA3 region of the rat hippocampus. The utility of this antibody quickly expanded
when several groups discovered that it could be used to identify very specific populations of
neurons in the normal, developing, and diseased or injured central nervous system. Despite
this body of literature, the identity of the antigen that the Py antibody recognizes remained
elusive. Here, immunoprecipitation experiments from the adult rat cortex identified the Py
antigen as neurofilament heavy chain (NF-H). Double immunolabelling of sections through
the rat brain using Py and NF-H antibodies confirmed the identity of the Py antigen, and
reveal that Py/NF-H+ neurons appear to share the feature of being particularly large in
diameter.  These include the neurons of the gigantocellular reticular formation, pyramidal
neurons of layers II/III and V of the cortex, cerebellar Purkinje neurons as well as CA3
pyramidal neurons. Taken together, this finding gives clarity to past work using the
monoclonal Py antibody, and immediately expands our understanding of the importance of
NF-H in neural development, functioning, and disease.
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Introduction
In 1989, a study by Woodhams et al. (1989) detailed the production and characterization of a
new antibody that labelled a subset of neurons in the hippocampus, cortex, cerebellum and
brain stem. Because the antibody was useful for distinguishing pyramidal neurons from the
CA3 region of the hippocampus both in vivo and in vitro, they called the monoclonal IgM
antibody . The usefulness of this antibody was almost immediately realized, as Raisman
and colleagues used it to identify and detail CA3 hippocampal transplants to adult rats (Field
et al., 1991), and Whittemore and colleagues that the Py antigen was expressed by
immortalized stem cells transplanted (and incorporating) into the CA3 region of the rat
(Shihabuddin et al., 1996). Subsequent work by Brook et al. (1997a and 1998) found that the
antibody stained neurons along the spinal column, most notably motor neurons, and the
neurons of . Additional work by Houweling et al. (1999) found that Py
labelled neurons in the developing spinal cord at very early stages of development (i.e.,
embryonic day 15). The antibody further proved useful for highlighting important changes in
anatomical structures of the brain and spinal cord in response to gene alterations, injury or
disease models.  Py, for example, was used to highlight cortical neurons affected by deletion
of the mouse-enabled gene, which displays midline crossing defects in the corpus callosum
(Lanier et al., 1999). In the red s nucleus, Py highlighted a loss of
cellular content after axotomy of the rubrospinal and spinocerebellar tracts, respectively
(Brook et al., 1997b and 1998). In a transgenic mouse model of amyotrophic lateral sclerosis
(G93A), Py was shown useful for detecting early changes in motoneurons before the onset of
neuronal cell death in the spinal cord (Joosten et al., 2001).
However, the identity of the antigen that the Py antibody recognises has, for almost 30 years,
remained elusive. Determining the antigen recognised by the Py antibody would be beneficial
not only for understanding the findings of past work that has used the antibody, but may also
allow for some understanding of what the function of such a protein might be for neurons that
express the antigen in the developing and adult central nervous system (CNS). Here,
immunoprecipitation experiments from the adult rat cortex have identified the Py antigen as
neurofilament heavy chain (NF-H). This finding was confirmed using double-label
immunofluorescence analysis in sections through the rat brain, which highlighted its
expression in a subset of neurons in the cortex, hippocampus, septum, basal forebrain, brain
stem and cerebellum. Coupling findings from studies using the Py antibody with studies
using the NF-H antibody should enhance our understanding of the role that NF-H plays in the
development, maturation, and diseased states of the mammalian CNS.
Methods
Py antibody production
A Py IgM hybridoma cell line (2011 clone) was quickly thawed in a 37°C water bath for 1
minute. The cell suspension was subsequently centrifuged at 300g for 5 minutes and the
supernatant discarded. The cells were suspended in a hybridoma medium (DMEM, 20%
horse serum, 1% non-essential amino acids, 1% glutamax, 1% penicillin streptomycin
fungizone) and centrifuged again at 300g for 5 minutes and cultured in a T25 flask at 37°C in
5% CO2. The cells were allowed to expand for 1 week, and were subsequently split 1:3 into
T75 flasks filled with hybridoma medium. The cells were grown at 37°C for an additional 2
weeks, when the supernatant was collected for use in immunofluorescence staining. The
antibody was stored until use at -80°C in aliquots to minimise freeze thawing cycles.
Tissue extraction
All procedures were approved by the Animal Welfare & Ethical Review Body (AWERB) at
Keele University, and were carried out under the licensed authority of the UK Home Office
(PPL40/3556). Adult, female Sprague Dawley rats (~230g weight) were given an overdose of
pentobarbitone anesthetic (0.5ml/ 100g) via an intraperitoneal injection, and transcardially
perfused with ice-cold sterile 0.9% sodium chloride. The brains were quickly removed and
layers II V of the cortex (i.e., areas which are known to express the Py antigen, based upon
immunofluorescence observations) were dissected from the dorsal region above the striatum.
Cortical tissue was placed on a small spatula and excess saline solution removed before
placing the sample into a 1.5ml Eppendorf tube. The dissected tissue was homogenised in
approximately four volumes (w/v) of modified RIPA buffer (1% NP40, 0.25% deoxycholate,
1mM EDTA, 150mM NaCl, in 50mM Tris-HCl, pH7.4) using a small pellet pestle. The
extracts were sonicated for 5 seconds, left on ice for 10 minutes, followed by centrifugation
at 13,000 g for 10 minutes at 4°C to pellet any insoluble material.
Immunoprecipitation
For immunoprecipitation with anti-NF-H: anti-mouse Pan Ig-
(Dynal, Oslo) were washed three times with 4% BSA in PBS (using a magnetic collector to
separate the beads from solution). The beads were then incubated with a monoclonal antibody
that recognises phosphorylated and non-phosphorylated forms of NF-H (Sigma; N0142)
) for 30 minutes at room temperature with gentle rolling. The beads
incubation for 1 hour at room
temperature with the rat cortex RIPA extract on a roller. The unbound material was
carefully removed from the beads and stored at -80°C until use. The beads were washed six
heating at 900C for 3
minutes (2% sodium dodecyl sulphate- SDS, 5% 2-
mercaptoethanol, 62.5 mM Tris-HCl, pH 6.8). The same method was used for
immunoprecipitation with the Py monoclonal antibody , except that a Protein L
matrix ( CBind L, Sigma) was used for antibody capture instead of Pan Ig magnetic
beads because the Py MAb is IgM class.
Western blotting
Protein samples were heated at 900C in SDS sample buffer (2% SDS, 5% 2-mercaptoethanol
62.5mM Tris-HCl, pH 6.8) for 3 minutes, separated on 4-12% SDS-PAGE gradient gel
(ThermoFisher Scientific), followed by transfer to nitrocellulose membrane over-night. After
blocking non-specific sites with 4% powdered milk solution, membranes were incubated with
either Py MAb (1/10), NF-H MAb (Sigma; N0142) (1/1000) or SMI-32 MAb (EMD
Millipore; NE1023) (1/1000) diluted in dilution buffer (PBS, 1% fetal bovine serum, 1%
horse serum and 0.1% BSA). Antibody reacting bands were visualized by development with
peroxidase-labelled rabbit anti-mouse IgG (1µg/ml in dilution buffer; Dako) (for NF-H and
SMI-32) or peroxidase-labelled goat anti-mouse IgM (1/2000; Jackson ImmunoResearch)
(for Py), and a chemiluminescent detection system (West Pico, Pierce).
To determine whether the epitope recognized by the Py antibody is glycosylated, electro-
blotted membranes were subject to sodium metaperiodate treatment to destroy pentose and
hexose carbohydrate epitopes by oxidation, as described by Woodward et al., (1985). To
ensure that the technique did not result in denaturation of protein epitopes, an additional
electro-blotted membrane was subject to the same conditions but without addition of
metaperiodate. Briefly, electro-blotted membranes were incubated in either 10mM sodium
meta-periodate (in 50mM sodium acetate buffer, pH 4.5) or just  50mM sodium acetate
buffer, pH 4.5 (for the controls), for one hour in the dark, followed by incubation with 50mM
sodium borohydride in PBS for 30 minutes. After rinsing several times with PBS, the blots
were blocked and developed in the same way as described above.
ImmunofluorescenceAdult, female Sprague Dawley rats (~230g in weight) were given an
overdose of pentobarbitone anesthetic (0.5ml/ 100g) via an intraperitoneal injection, and
cardiac perfused with a 4.0% solution of paraformaldehyde (PFA) in Tris-buffered saline
(TBS). The brain was removed and placed in PFA overnight.  The following day specimens
were transferred to a 30% sucrose solution in TBS, and allowed to sink fully in the solution at
room temperature (RT). Subsequently, specimens were placed on a sliding, freezing
microtome and 40µm coronal or sagittal sections cut through the brain from the most anterior
or rostral section in the coronal plane in which the striatum can be recognised, to the
cerebellum. Sections were placed in 24 well plates containing TBS with sodium azide, and 1
in 6 sections were taken for immunofluorescence using Py and NF-H antibodies.
For immunostaining, sections were rinsed 3 times in TBS, and subsequently incubated in a
0.5% Triton X-100 / TBS solution (TxTBS) for 1 hour at RT. Double-label antibody staining
was conducted sequentially to avoid cross-reaction with secondary antibodies. Control
sections were processed at the same time in the absence of either the Py or NF-H primary
antibody, but included all steps containing secondary antibodies. Sections were first
incubated overnight in a 1:500 dilution of NF-H (Sigma; N0142) in TxTBS. The following
day, the sections were rinsed 3 times for 5 minutes in TBS and subsequently placed in a
1:500 dilution of Alexa Fluor® 594 goat anti-mouse IgG secondary (Life Technologies) in
TxTBS for 2 hours. Sections were subsequently rinsed 3 times for 20 minutes in TBS, and
placed in a 1:50 dilution of Py antibody in TxTBS overnight. The following day sections
were rinsed 3 times for 5 minutes, and subsequently incubated in a 1:500 dilution of Alexa
Fluor® 488 goat anti-mouse IgM (Life technology) and 0.5µg/ml DAPI in TxTBS for 2
hours. Finally, the sections were rinsed 3 times for 20 minutes in TBS, and then mounted and
coverslipped for microscopy. Images were captured using a Nikon Eclipse 80i microscope
fitted with a Hammamatsu fluorescent camera operated with the NiS Elements computer
software.
Results
Monoclonal antibody Py recognizes neurofilament heavy chain
Immunoprecipitation from a rat cortex extract using Py MAb attached to protein-L, followed
by mass spectrometry analysis of the captured material, resulted in the identification of
several Py-antigen candidates (data not shown). Whilst some of these presumably bound to
the protein-L non-specifically, only one candidate, neurofilament heavy chain (NF-H),
corresponded to the approximate molecular weight of the major band recognised by Py MAb
on a western blot (~200kDa). Immunoprecipitations from a fresh extract of rat cortex using
either Py MAb or an anti-NF-H MAb, followed by western blot analysis of the captured
material, confirmed that immunoprecipitation and detection of the ~200kDa antigen was
reciprocal (Figure 1A). Control pull-downs, using cortex extract added to Dynabeads without
antibody (for NF-H) and Protein-L without antibody (for Py), verified that the antigen did not
bind to either matrix non-specifically (Figure 1A).
Py 146 kDa glycoprotein
Joosten et al., 2001; Houweling et al., 1999; Brook et al., 1997a; Brook et al., 1997b). To
determine whether the epitope recognized by the Py antibody is glycosylated, electro-blotted
membranes were subject to sodium metaperiodate treatment to destroy pentose and hexose
carbohydrate epitopes by oxidation (Woodward et al., 1985). This treatment did not abolish
immunoreactivity of the Py MAb, suggesting that the Py antibody epitope is unlikely to be
glycosylated (Figure 1B).
The western blot band recognized by the Py and the NF-H MAb on eluates from both
antibodies appeared to have a slightly slower electrophoretic mobility, compared to the
unbound material following immunoprecipitation (Figure 1A). To confirm this, and to
determine whether the antibodies immunoprecipitate a particular subset of the NF-H in the
cortex extract, the eluates were subject to much longer separation on an SDS-PAGE gel, to
better resolve higher molecular weight proteins before western blotting. Comparison of the
material eluted from the Py and NF-H antibodies against the cortex extract before pull-down
and the unbound material after pull-down revealed some interesting insights
(Figure 1C and D). While the Py and the NF-H MAb both detected a sharp, well-resolved
band of the same apparent molecular weight in the eluates, the NF-H MAb detected a band
spanning a greater molecular weight range in the input and unbound material, compared to
the Py MAb. Analysis of the same samples with an additional, commercially available
antibody against NF-H, SMI-32, revealed the same pattern of immunoreactivity as seen with
the NF-H antibody. Of note is the more discrete-sized band recognized by the Py MAb in the
input and unbound (Figure 1C and D), and the clear distinction that the Py MAb makes
between the faster electrophoretic mobility of the unbound material compared to the slower
electrophoretic mobility of the protein that was immunoprecipitated (Figure 1C and D).
Taken together, these findings demonstrate that the Py and NF-H antibodies recognize the
same sized isoform of NF-H in rat cortex RIPA extracts before protein denaturation, but
following denaturation in SDS-sample buffer, a wider range of NF-H molecular weight forms
presumably varying in the degree of phosphorylation or other post-translational
modification are detectable by the NF-H MAb, compared to the Py MAb.
Py and NF-H co-localize in the brain
Immunofluorescencedouble-labelling with Py and NF-H antibodies yielded an overlapping
staining pattern throughout the rat brain (Figures 2-5), while control sections (i.e., sections
immuno-processed with both secondary antibodies, but excluding either of the primary
antibodies) yielded labelling in only a single channel (Figure 6). DAPI labelling in each
experimental condition indicates the presence of cells and confirms the integrity of the tissue.
Co-localization of Py and NF-H in coronal sections from rostral regions of the brain
(approximately -0.12mm from Bregma; Paxinos and Watson, 2005) was notable throughout
the cortex, septal nuclei, and basal forebrain (Figure 2). While layer II / III and V of the
cortex in this rostral plane showed obvious colocalization of Py and NF-H in neurons with
large apical dendrites (Figures 2A-H), staining in the septal region was exclusively fibrous,
and the basal forebrain a mixture of cellular and fibrous staining (Figures 2I-P). In the
cortex, pyramidal cells in both layers II/III and V displayed intense staining of the cell body,
proximal basal dendrites, as well as the full length of the apical process (Figures 2A-H; and
7A-D).  Branching of the apical process in the most superficial regions of the cortex could be
seen emanating from neurons in layer II/III. Fibers stained in the septal region (Figure 2I-L)
were thick, though there was no obvious cell body staining to conclusively indicate that they
were dendrites.  In contrast, a small region of the basal forebrain showed a mixture of fiber
(dendritic) and somatic staining (Figure 2M-P).
Just caudal to this (approximately -0.48mm from Bregma; Paxinos and Watson), coronal
sections show Py and NF-H colocalizing in the soma and apical dendrites of neurons in
Layers II / III and V of the cortex (Figures 3A-H). However, though pyramidal neurons in the
cingulate and somatosensory regions of the cortex were intensely immunopositive, the
primary and / or secondary motor cortex appeared to have little or no immunoreactivity
(Figures 3A-H). In this same plane of section, thick fiber staining highlighted the globus
pallidus (Figures 3I-L) with both Py and NF-H antibodies, thoughit was not obvious whether
these were dendritic or axonal.  There was, however, a complete absence of fiber or cell body
staining in the neighboring striatum..
Even more caudally (approximately -3.48mm from Bregma; Paxinos and Watson, 2005),
coronal sections showed somatic and dendritic staining throughout the tightly packed CA3
region of the hippocampus (Figures 4A-H; 7E-H), and exclusively fibrous staining in the
thalamus (Figures 4I-L). In the hippocampus, the soma of pyramidal neurons along with a
short portion of their apical process were intensely Py/NF-H+ (Figure 7E-H). In both the
thalamic and hippocampal region, staining in the red (NF-H) channel was occasionally more
obvious (particularly in white matter tracts), compared to the staining seen with the Py
antibody (green). This slight difference in antibody specificity may bear some relationship to
the slightly narrower range of molecular weight forms that the Py antibody recognizes after
protein denaturation by western blot, compared to the NF-H antibodies (Figure 1).
Caudally, in the cerebellum and brain stem (Figure 5), double labelling of Py and NF-H in
sagittal sections showed staining in Purkinje cell soma and dendrites (Figures 5A-D), and in
the soma of cells in the gigantocellular reticular formation (Figures 5E-L). Within the
cerebellum, there was a notable absence of staining of any of the numberous neurons of the
molecular and granuale cell layer (Figure 5A-D).  Both the soma and proximal (thick)
dendritic process of Purkinje cells were clearly Py/NF-H+, though the more fine structures of
the dendritic tree were not obvious (Figures 5A-D; 7I-L). Again, staining with the NF-H
antibody was more apparent in the white matter tract of the cerebellum in comparison to Py
immunolabelling (Figure 5B-D). In the brain stem, the loosely packed group of neurons in
the region of the gigantocellular reticular formation were intensely Py/NF-H+ (Figure 5E-L).
Though fine tubular staining could be seen throughout the soma of the cells, there was little
obvious neurite staining surrounding them (Figure 7M-P).
Discussion
Previously, the monoclonal antibody Py was shown to be useful for revealing intricate details
of subsets of neurons within the brain and spinal cord. However, the identity of the antigen
the antibody recognises remained a mystery. Here, immunoprecipitation from extracts of rat
cortex, and subsequent immunofluorescencecharacterization shows that Py recognises the
neurofilament heavy chain subunit.
In the original article detailing the production of the Py antibody, Woodhams et al (1989)
describe how the antibody recognized a major band at 146kDa and a fainter band at 166kDa
in various rat brain homogenates. However, in our hands, the major band recognized by the
Py antibody has an apparent molecular weight of approximately 200kDa, with some much
fainter bands present at lower molecular weights (see Figure 1A). In contrast to the western
blots shown here that were developed with an anti-IgM secondary antibody, Woodhams et al
(1989) developed their Py blot using an anti-IgG secondary antibody that potentially lacked
the required specificity to detect the (IgM-class) Py MAb. It is also possible that in previous
attempts to resolve the Py antigen on an SDS-PAGE gel, the length of time the extracts were
subject to electrophoresis was insufficient to enable the 200kDa protein to enter the resolving
gel.
Py has historically been referred to as a 146 kDa glycoprotein
Joosten et al., 2001; Houweling et al., 1999; Brook et al., 1997a; Brook et al., 1997b),
presumably because it was a glycoprotein enriched fraction, isolated from a lentil lectin-
affinity column, that was used for immunization (Woodhams et al., 1989). Although a
glycosylated form of NF-H has been described previously (Cheung and Hart, 2008), our data
suggest that the epitope that is recognized by the Py MAb is not glycosylated, since periodate
treatment to destroy pentose and hexose carbohydrate epitopes by oxidation (Woodward et
al., 1985) did not abolish immunoreactivity of the Py MAb (Figure 1). In the future, it will be
interesting to determine whether differences in post-translational modification (e.g.
phosphorylation and / or glycosylation) explain the narrower molecular weight range of NF-
H that is recognized by the Py MAb on western blots and whether this has any functional
relevance.
Morphologically, the cells that stain positive for Py/NF-H appear to have several
characteristics in common. Neurons that express the antigen are large in size and many
support large (typically apical) dendritic processes. This is illustrated well in layers II / III
and V of the cortex (Figures 2-3), and in the CA3 region of the hippocampus (Figure 4).
Within the cerebellum, there is a striking contrast between the immunoreactivity of the large
cells in the Purkinje cell layer, and the lack of any detectable Py/ NF-H staining in the
adjacent internal granule cell and molecular layers (Figure 5). In addition, the particularly
large neurons in the gigantocellular reticular formation (Figure 5) are similarly
immunopositive for Py/NF-H, while many brain stem neurons remain negative. Such
observations are similar to work in the spinal cord by Brook et al., (1997a) who showed that
only large diameter alpha motoneurons and are positive
for Py, while the small diameter neurons in the substantia gelatinosa are negative. This
observation suggests that one possible explanation for the specific staining pattern of a subset
of cells could be structural, in that the larger subunit of neurofilament may be important to
the maintenance of the cytoskeletal framework of particularly large neurons. Indeed, work
by Elder et al. (1998), have shown that mice with NF-H knocked out fail to develop large
diameter axons in both the central and peripheral nervous system.
A notable exception to large diameter neurons staining positive for Py/NF-H+ are the very
large pyramidal neurons (particularly, Betz cells) in the motor cortex.  Betz cells are among
the largest neurons in the mammalian brain, yet they do not appear to stain positive for
Py/NF-H.  In an ultrastructural analysis of Betz cells in the human brain, Sasaki and Iwata
(2001) have shown that neurofilament staining of these large neurons is rare, but that
neurofilament accumulation is increased in Bunia-like bodies in Betz cells of human brains >
65 years of age and in neurons of the anterior horn of the spinal cord of ALS patients (Sasaki
et al., 1989). Also, they observed that Betz cells appear to contain filaments that are much
thicker than neurofilaments (i.e., 20-25nm in diameter).  Such observations suggest that Betz
cells have a particular cytoskeleton that is not dominated by a typical neurofilament structure,
and that neurofilaments may mainly occur in these cells with increasing age or the presence
of unusual cytoplasmic inclusions.
A second commonality among many of the cells and processes that stain positive for Py/NF-
H, is that they reside in regions of the brain that appear to be particularly vulnerable to
dementia or age related degeneration. The high expression of Py/NF-H in the cortex and CA3
hippocampal region, for example, correlates well with patterns of abnormal tau
phosphorylation in disease (Blazquez-Llorca et al., 2011). Furthermore, staining
Meynert, which is known to be significantly affect by both and
(Liu et al., 2015). Similarly, connections to and from the
cerebellum (Guo et al., 2016) and the septal region of the brain (Stroessner-Johnsson et al.,
1992) are known to be affected by neurodegenerative disease or age related cell neuronal
loss. Interestingly, seminal work by Chapman et al., (1989) showed that sera from AD
patients showed a high content of antibodies directed again NF-H, and Roder and Ingram
(1991) that age and AD- related changes in ATP may affect neurofilament/tau kinase activity.
Though these observations should not be overstated (as neurons in many regions of the CNS
suffer age-related degeneration or are vulnerable to neurodegenerative disease and the
dopaminergic neurons of the substantia nigra pars compacta are not Py/NF-H+) it seems
important to continue to explore how large neurons may be more vulnerable to age related
degeneration / disease (Mosconi et al., 2008), and whether Py/NF-H may provide a useful
marker for these cells. Seminal work by Guo et al. (1995) and more recently by Veerana et al.
(2011), in fact, strongly indicate that ageing may result in a hyperphosphorylation of NF-H;
making cells more susceptible to degeneration. What is almost certain is that NF-H is known
to be affected in (and therefore serve as a good marker for) a variety of neurodegenerative
conditions. Work by Collard et al. (1995) provided some of the first evidence for NF-H
accumulations being a factor in the degenerative process of amyotrophic lateral sclerosis
(ALS). More recent work by Schulz et al. (2013) have shown that reduced phosphorylation of
NF-H may be a contributing factor in neurofibromatosis type 2, and Sellner et al. (2014) that
NF-H may be a useful pathological and prognostic marker for acute encephalitis.
Interestingly, NF-H has also been shown to be a useful marker for the ganglion cells in the
retina whose axons have been damaged (Drager and Hofbauer, 1984), as well regenerating
fibers of retinal ganglion cells (Bates and Meyer, 1993).
In conclusion, the identification of the Py antigen sheds light on past work that has utilized
the monoclonal antibody Py, and, when combined with studies using the NF-H antibody,
expands our understanding of this protein in the developing, mature and dysfunction CNS. It
will be important in the future to gain more understanding of why Py/NF-H expression in the
brain appears mostly restricted to large diameter neurons, and whether this feature is relevant
to neurodegenerative disorders and CNS injuries. The work presented here, and the
collective work with Py and NF-H from previous studies, suggests a particular structure and
function to cells which express this antigen in the brain and spinal cord, and illustrates how
ultrastructural changes in these cells can be identified (in detail) in both normal and abnormal
neural conditions.
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Figure legends
Fig. 1 Reciprocal immunoprecipitation and western blot detection of Py and NF-H.
(A) Western blot analysis of immunoprecipitates from a RIPA extract of rat cortex using
either Py MAb or an anti-NF-H MAb confirmed that immunoprecipitation and detection of
the ~200kDa antigen was reciprocal. The control pull-down lanes refer to cortex extract
incubated with Dynabeads without antibody (for NF-H) and Protein-L without antibody (for
-IgM secondary
antibody with the IgM heavy chain that eluted from the Protein-L. The bands identified by
-reaction of the Py or anti-IgM antibody with a
component of the Protein-L that detached during elution of the immunoprecipitate in SDS-
sample buffer (B) Sodium meta-periodate treatment of electro-blotted membranes did not
abolish immunoreactivity of the Py MAb. (C) Western blot analysis of the cortex extract,
unbound extract (after pull-down) and eluates, following extended electrophoresis to separate
higher molecular weight forms, is shown for the Py MAb immunoprecipitation and in (D) for
the NF-H immunoprecipitation. Both sets of immunoprecipitates (C and D) were also
analyzed using another commercially available anti-neurofilament heavy antibody, SMI-32
Fig. 2 Immunofluorescence of coronal sections through the brain reveals colocalization
of Py and NF-H in the cortex, septum, and basal forebrain.   At approximately -0.12mm
from bregma, Py and NF-H staining was evident in Layers II/III and V of the cingulate (A-D)
and dorsal neocortex (E-H), as well as the fimbria (FI) and lateral septal (LS) regions (I-L),
and the basal forebrain (M-P).  While the soma (arrows B and F) and apical process
(arrowheads B and F) of neurons in the cortex showed evident staining in layers II/III and V,
there was only fibrous staining in the septal region, and a mixture of cell body and fiber
staining in the basal forebrain.  Scale bars in A and M = 200µm; E = 100µm; I = 400µm.
(Diagram adapted from; Paxinos and Watson, 2005)
Fig. 3 Immunofluorescence of coronal sections through the brain reveals an absence of
Py and NF-H staining in the motor cortex, and only fiberous staining in the globus
pallidus. While the neurons in Layers II/III and V of the somatosensory (arrowhead 3B) and
cingulate cortex (arrow 3B) stained intensely for Py and NF-H (A-H), there was a virtual
absence of staining in much of the primary (M1) and secondary (M2) motor cortex (*3B),
particularly in Layers II/III (A-H).  Ventral to this, fibrous staining could be seen throughout
the globus pallidus (GP), though the whole of the striatum (CPu) was immuno-negative for
Py and NF-H (I-L).  Scale bars in A and I = 400µm; E = 200µum. M =  motor cortex.  Cg =
cingulate cortex. (Diagram adapted from; Paxinos and Watson, 2005)
Fig. 4 Immunofluorescence of coronal sections through the brain reveals overlapping
staining for Py and NF-H in the hippocampus and thalamus.  In caudal regions of the
brain, Py and NF-H had completely overlapping staining in the CA3 region of the
hippocampus (A-H), and reticular (rt) and ventral posteriormedial (VPM) and ventral
posteriolateral (VPL) thalamic nuclei (I-L).  Note that; although the cell soma and apical
processes of neurons in the stratum lucidum (SLu) and CA3 regions of the hippocampus are
labelled for Py and NF-H (E-H), only fibrous staining could be seen in nuclei of the thalamus
(I-L).  Scale bars in A and I = 400µm; E = 200µm. (Diagram adapted from; Paxinos and
Watson, 2005)
Fig. 5 Immunofluorescence of sagittal sections through the brain reveals overlapping
staining for Py and NF-H in the cerebellum and brain stem.  In caudal regions of the
brain, Py and NF-H stained large cells of the Purkinje cell layer (PCL) of the cerebellum (A-
D) while the much smaller, but numerous, neurons of the internal granule cell (IGL) and
molecular layer (ML) were negative.  Similarly, in the brain stem, low (E-H) and high (I-L)
powered images show that the very large cells of the gigantocellular group of the reticular
formation (arrowheads J) are strongly positive for Py and NF-H staining. Boxed area in F,
shown at higher magnification in I-J. Scale bars in A and E = 200µm; I = 100µm
Fig. 6: Control staining for Py and NF-H show no cross reactivity with secondary
antibodies. Low magnification (1x) image of coronal section of the rat brain double-labelled
using Py (IgM) and NF-H (IgG) primary antibodies and corresponding anti-IgM (green) and
anti-IgG (red) secondary antibodies (A-D).  Inclusion of both primary and corresponding
secondary antibodies reveal overlapping staining in the brain(D).  In control sections, where
the NF-H antibody was omitted (E-H), but both secondary antibodies were applied, no
staining could be seen in the red channel (G).  Similarly, in control sections where the Py
antibody was omitted (I-L), but both secondary antibodies were applied, no staining could be
seen in the green channel (J). M = motor cortex.  cc = corpus callosum.  ac = anterior
commissure.  CPu = striatum. Scale bar in A = 1mm, E = 100µm, I = 200µm
Fig. 7: High magnification, confocal images, showing cellular detail of Py/NF-H
colocalization: In layers II/III and V of the cortex, the soma, proximal basal dendrite (arrow
head), and apical process (arrows) of pyramidal neurons were Py/NF-H+ (A-D).  Similarly,
in the tightly packed CA3 region of the hippocampus, the soma of large neurons and a short
segment of their dendritic (apical) processes (arrow) could be seen in all pyramidal neurons.
(E-H).  In the cerebellum (I-L), it was notable that none of the vast number of cells in the
granule cell layer (IGL),  or the sparse cells of the molecular layer (ML) were
immunopositive for Py/NF-H.  By contrast, the monolayer of large Purkinje cells and their
proximal dendritic tree were intensely Py/NF-H+.  In the brain stem (M-P), the sparse
neurons of the gigantocellular reticular formation showed intense Py/NF-H staining of their
soma, but little notable staining of neurite processes. Scale bars = 25µm.







